American College of Rheumatology (ACR) Convergence 2025
Oct 18, 2025
1 min read
Kali Therapeutics Announces Upcoming Poster Presentations at the American College of Rheumatology (ACR) Convergence 2025
top of page
Recent Posts
See AllKali Therapeutics, a clinical-stage biotechnology company pioneering next generation immune-resetting and multi-specific therapies, today announced its selection as a winner of the 2026 Endpoints 11,
Kali Therapeutics, a clinical-stage biotechnology company pioneering next-generation immune-resetting and multi-specific therapies, today announced that the U.S. Food and Drug Administration (FDA) has
SAN MATEO, CA. – June 08, 2026 – Kali Therapeutics, a clinical-stage biotechnology company pioneering next-generation immune-resetting and multi-specific therapies, today announced that preclinical da
bottom of page